Innate Pharma (IPHYF) Equity Average (2018 - 2019)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Innate Pharma's Equity Average history spans 2 years, with the latest figure at $215.8 million for Q4 2019.

• For Q4 2019, Equity Average rose 47.74% year-over-year to $215.8 million; the TTM value through Dec 2019 reached $215.8 million, up 47.74%, while the annual FY2019 figure was $215.8 million, 47.74% up from the prior year.
• Equity Average reached $215.8 million in Q4 2019 per IPHYF's latest filing, up from $146.0 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $215.8 million in Q4 2019 to a low of $146.0 million in Q4 2018.

Peer Comparison